Michael Birrer, MD, PhD, Harvard Medical School, discusses what he hopes to discover as factors that may influence long-term survival in patients and survivors of ovarian cancer.

Birrer is involved in a study examining psychosocial, quality of life, and genomic factors at diagnosis that correlate with survival lasting longer than 10 years. Hopefully, he says, this will lead to more personalized medicine so that every patient with ovarian cancer can become a long-term survivor.

Videos

Michael Birrer, MD, PhD, Harvard Medical School, discusses what he hopes to discover as factors that influence long-term survival in patients and survivors with ovarian cancer. 

Michael Birrer on Predicting Outcomes in Ovarian Cancer

Michael Birrer, MD, PhD, Harvard Medical School, discusses the importance of personalized care for ovarian cancer.

Birrer was involved in conducting a large study that examined elements at diagnosis, such as tumor biomarkers and quality of life, and determining if they can predict why some women with ovarian cancer live longer than others.

This research is important, Birrer says, because it can help personalize care, thus resulting in better survival outcomes and quality of life, and reducing toxicities. As of right now, patients with ovarian cancer, though they fall on a broad spectrum of survival, are treated with a “one size fits all” approach.

Michael Birrer, MD, PhD, Harvard Medical School, discusses the importance of personalized care for ovarian cancer.
 

Michael Birrer, MD, PhD

Articles

Michael Birrer on Predicting Outcomes in Ovarian Cancer

Michael Birrer Discusses Personalization of Ovarian Cancer Care